Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-19

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved Apotex Corp's supplemental application for fluvoxamine maleate, i.e., the generic fluvoxamine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)